Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: December 6, 2007
UROPLASTY, INC.
(Exact name of registrant as specified in charter)
| 000-20989 (Commission File No.) | 41-1719250 (IRS Employer Identification No.) |
Minnesota
(State or other jurisdiction of incorporation or organization)
(State or other jurisdiction of incorporation or organization)
5420 Feltl Road
Minnetonka, Minnesota 55343
(Address of principal executive offices)
Minnetonka, Minnesota 55343
(Address of principal executive offices)
952-426-6140
(Registrant’s telephone number, including area code)
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name and Address)
(Former Name and Address)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 of the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
| Item 1.01. Entry into a Material Definitive Agreement | ||||||||
| Item 9.01. Financial Statements and Exhibits | ||||||||
| SIGNATURES | ||||||||
| Form of Supply Agreement | ||||||||
Table of Contents
Item 1.01. Entry into a Material Definitive Agreement
In December 2007, we entered into a supply agreement, commencing on December 6, 2007 and ending on March 31, 2010, with Tyco Healthcare Group LP acting through its Uni-Patch Division, for purchase of surface electrodes for our Urgent PC® system. The agreement requires of us to deliver, on a monthly basis, to Uni-Patch a non-binding, rolling twelve-month forecast of our anticipated purchases, of which the forecast for first three months becomes a firm purchase commitment.
Item 9.01. Financial Statements and Exhibits
(c) Exhibits (filed herewith)
| Exhibit No. | Description | |
| 10.33 | Form of Supply Agreement between Uroplasty, Inc. and Tyco Healthcare Group LP acting through its Uni-Patch Division, dated December 6, 2007. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: December 7, 2007
| UROPLASTY, INC. | ||||
| By: | /s/ Mahedi A. Jiwani | |||
| Mahedi A. Jiwani | ||||
| Vice President, Chief Financial Officer and Treasurer | ||||